<?xml version="1.0" encoding="UTF-8"?>
<p>The antibacterial activities of pure compound 
 <bold>309</bold> was evaluated against Gram-positive bacteria 
 <italic>Staphylococcus aureus</italic> and 
 <italic>Bacillus subtilis</italic> and Gram-negative bacteria 
 <italic>Pseudomonas aeruginosa</italic> and E
 <italic>scherichia coli</italic> using the disk diffusion assay. The new compound 
 <bold>309</bold> showed inhibitory activity against 
 <italic>S. aureus</italic> at 0.04 µg/paper disk, and the diameter of inhibition zone was 0.71 cm. The MIC for compound 
 <bold>309</bold> against 
 <italic>S. aureus</italic> was 100 µg/mL using the broth microdilution method, while streptomycin was employed as the positive control with an MIC of around 50 µg/mL [
 <xref rid="B102-ijms-22-00959" ref-type="bibr">102</xref>].
</p>
